Joanna Szydzik | Ruth Palmer Labhttps://deploy-preview-3--ruthpalmerlab.netlify.app/author/joanna-szydzik/Joanna SzydzikHugo Blox Builder (https://hugoblox.com)en-ushttps://deploy-preview-3--ruthpalmerlab.netlify.app/author/joanna-szydzik/avatar_hu67c13af330c5af2d5a32c5e81e954420_4509_270x270_fill_lanczos_center_3.pngJoanna Szydzikhttps://deploy-preview-3--ruthpalmerlab.netlify.app/author/joanna-szydzik/ATR inhibition enables complete tumour regression in ALK-driven NB mouse modelshttps://deploy-preview-3--ruthpalmerlab.netlify.app/publication/atri1/Wed, 24 Nov 2021 00:00:00 +0000https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/atri1/Repotrectinib (TPX-0005) effectively reduces growth of ALK-driven neuroblastoma cellshttps://deploy-preview-3--ruthpalmerlab.netlify.app/publication/repotrectinib/Wed, 18 Dec 2019 00:00:00 +0000https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/repotrectinib/Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathwayshttps://deploy-preview-3--ruthpalmerlab.netlify.app/publication/phosphoproteome_alk/Tue, 20 Nov 2018 00:00:00 +0000https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/phosphoproteome_alk/